J&J reportedly eyeing Shockwave Medical for takeover
Cardiovascular device maker Shockwave has a marketed C²⁺ IVL catheter for the treatment of severely calcified coronary artery disease.
28 March 2024
28 March 2024
Cardiovascular device maker Shockwave has a marketed C²⁺ IVL catheter for the treatment of severely calcified coronary artery disease.
Medtronic has said its latest Evolut FX+ TAVR system can offer larger coronary access windows through a modified diamond-shaped frame.
The software is planned to be made available on bkActiv, bk3000/5000, and bkSpecto active imaging systems.
The Celeste phototherapy device uses light to treat symptoms in Parkinson’s patients linked to the circadian system.
The Synaptive’s Modus X now features near-infrared fluorescence powered by custom LED lighting.
The SleepStageML is designed to help improve the diagnosis and evaluation of sleep and sleep-related disorders.
With the sale, Ypsomed intends to focus on its diabetes care business.
Roche expects to roll out the device in the US at the end of Q2 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.